A multicenter, randomized, double blind, double dummy, parallel group study to compare effects of Coreg CR [carvedilol controlled release] and Coreg IR [carvedilol immediate release] on ejection fraction in subjects with stable chronic heart failure

Trial Profile

A multicenter, randomized, double blind, double dummy, parallel group study to compare effects of Coreg CR [carvedilol controlled release] and Coreg IR [carvedilol immediate release] on ejection fraction in subjects with stable chronic heart failure

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2016

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Acronyms COMPARE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Jan 2008 The expected completion date for this trial is now 1 Apr 2008.
    • 07 Aug 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top